News and blogs
166 results found.
Acceleration through strategy and science: highlights from our 2025 Research Symposium
In July, 120 leading blood cancer researchers and partners gathered for Blood Cancer UK’s Research Symposium at the Royal College of Physicians. With 14 presentations on 7 different blood cancers, researchers shared bold ideas and their latest progress a
Manchester researcher awarded £300k as Blood Cancer UK launches £70 million strategy
A researcher at the University of Manchester has been awarded a 3-year research fellowship as Blood Cancer UK launches a bold new strategy to invest £70 million in life-saving research over the next five years.
Cambridge researchers awarded £700k as charity launches £70 million strategy to beat blood cancer
Researchers at the University of Cambridge have been awarded two research fellowships as Blood Cancer UK launches a bold new strategy to invest £70 million in life-saving research over the next five years.
We've come so far but we're not done yet: accelerating research progress
Blood Cancer UK are accelerating progress through research and will invest £70m in the next five years.
Harnessing the power of T-cells in stem cell transplants
Stem cell transplants can be a life-saving treatment for people with myeloma, a type of blood cancer that can be treated but currently has no cure. Dr Dimeloe tells us how she is harnessing the power of T-cells in her research.
Patients on NHS are first in the world to access new myeloma drug
Around 3,600 patients across England and Wales every year will now be eligible for this treatment combination.
How are clinical trials going to help beat blood cancer in a generation?
On clinical trials day we want to celebrate the vital role clinical trials play in improving survival for people with blood cancer. Read more about how we are supporting clinical trials.
Bone marrow test that spots residual leukaemia in trial could help improve survival
Researchers at King’s College London have found a test that detects traces of disease in the bone marrow of people with acute myeloid leukaemia (AML), a type of blood cancer. The procedure identified signs of AML returning in blood cancer patients before
New research shows a common diabetes drug may prevent aggressive leukaemia
Metformin appears highly specific to people with a certain DNA change at high risk of developing AML rather than being a generic treatment. This specificity makes it especially compelling as a targeted prevention strategy.
A new era of funding for blood cancer research
We’re thrilled to introduce the Transformational Research Awards. A major step forward in our mission to fund pioneering research to transform blood cancer treatment for all ages.
Blood cancer survivor is ‘luckiest man alive’ as treatment helps gain approval for use on NHS
England’s drug regulators have recommended two new treatments for blood cancer for use on the NHS.
AI: it’s not all “robot uprisings” - A true force for good in the healthcare space
Read more how blood cancer researcher Professor Daniel Royston is using AI to help improve the diagnosis and treatment of blood cancer.
Our highlights from the 2024 ASH conference
Read more on highlights from the 2024 annual American Society of Haematology (ASH) conference
Repeat COVID-19 jabs offer protection for the immunocompromised
Those with detectable antibodies were less likely to contract the virus or require hospital care if they had COVID-19.
The researcher and charity trustee whose received an OBE
The King’s New Years Honours list has been announced with Blood Cancer UK's trustee awarded an OBE for services to children.
Looking back at a year of magic moments in blood cancer research
We look at our top 3 research moments from another incredible year.
Blood cancer UK reacts to £100m investment into regional hubs for clinical trials
We welcome the government’s investment of £100 million in public-private investment to establish 20 new Commercial Research Delivery Centres (CRDCs) across the UK.
Stem cell transplant research gives hope to those with blood cancer
Blood Cancer UK-funded researchers at the University of Birmingham have identified a key target, CD70, to reduce the likelihood of ‘graft-versus-host disease’ which people with blood cancer can develop after receiving a life-saving stem cell transplant.
New blood cancer drugs in Scotland approved
Regulators in Scotland, has approved two new blood cancer treatments for use on the NHS in Scotland. A CAR-T therapy for diffuse large B-cell lymphoma is one of the treatments.
Interferon supplies for people with MPNs (Pegasys)
Find out what Blood Cancer UK is doing to solve the UK shortage of pegylated interferon alfa 2a (Pegasys), and what you can do if you take Pegasys to treat an MPN.
